ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing... Show more
PRPH is expected to report earnings to fall 90.32% to -18 cents per share on May 08
Q1'25
Est.
$-0.18
Q4'24
Missed
by $1.62
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.25
Q1'24
Beat
by $0.21
The last earnings report on March 31 showed earnings per share of -186 cents, missing the estimate of -23 cents. With 552.29K shares outstanding, the current market capitalization sits at 116.75M.